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Excessive daytime sleepiness (EDS) is a prevalent sleep-related complaint across the
general population and has been reported to be associated with headache. Tension-type
headache (TTH) is the most commonly encountered headache and accounts for a
significant amount of disease burden. However, the association between EDS and
TTH is currently scarce. In the present study, we investigated the impact of EDS on
the prevalence and clinical presentation of TTH. We utilized data from the Korean
Headache-Sleep Study, a national survey that sought to identify headache and sleep
characteristics in Korean adults. Participants with an Epworth sleepiness scale score
greater or equal to 11 were considered as having EDS. Of the 2,695 participants enrolled,
570 (21.2%) and 313 (11.6%) had TTH and EDS, respectively. EDS was highly prevalent
in individuals with chronic tension-type headache (CTTH) than in those without headache
(35.7 vs. 9.4%, p < 0.001). The prevalence of EDS in episodic tension-type headache
(ETTH) individuals with a headache frequency <1 per month (8.3%, p = 0.511) and
ETTH individuals with a headache frequency of 1–14 per month (13.5%, p = 0.054)
was not significantly different from that in individuals without headache (9.4%). TTH
participants with EDS had a higher headache frequency per month (4.3 ± 8.1 vs. 1.7 ±
4.2, p = 0.013), more severe headache intensity (Visual Analog Scale, 5.0 [3.0–6.0] vs.
4.0 [3.0–6.0], p = 0.008), a higher impact of headache (Headache Impact Test-6 score,
47.1 ± 7.3 vs. 43.5 ± 7.6, p < 0.001), and a higher prevalence of depression (12.7 vs.
3.2%, p < 0.001) than TTH participants without EDS. Consequently, CTTH is associated
with higher EDS prevalence compared to ETTH and without headache. Moreover, TTH
with EDS had more severe TTH symptoms compared to TTH without EDS.
Keywords: excessive daytime sleepiness, tension-type headache, headache, sleep, epidemiology
INTRODUCTION
Excessive daytime sleepiness (EDS) is a well-known complaint encountered in sleep clinics and
can occur in up to 12% of the general population (1, 2). EDS can result in reduced quality of life,
accidents, reduced performance, and cognitive and mood impairment (3–5). Various neurological
and psychological conditions have been reported to contribute to EDS. Patients with common
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neurological disorders such as parkinsonism, multiple sclerosis,
stroke, and epilepsy often present with EDS.Moreover, a previous
study showed that individuals with depression, anxiety, and
schizophrenia often reported EDS (5).
Tension-type headache (TTH) is the most prevalent type
among primary headaches and individuals with TTH usually
have mild or no disability. However, some individuals with TTH
experience disabling symptoms that result in a significant amount
of disability and reduced quality of life (6). Because of its high
prevalence, the disease burden of TTH is estimated to be greater
than that of migraine (7).
Previous studies have reported a significant association
between EDS and headache. It has been reported that
migraineurs experience more EDS than non-migraineurs, with
EDS being associated with the exacerbation of migraine
symptoms (8, 9). Frequency of EDS was shown to be higher
among individuals with episodic and chronic migraine than
among individuals without headache (10, 11). However, there
is currently limited information on the prevalence of EDS in
TTH individuals and the impact of EDS on TTH. Therefore, we
conducted a study with a population-based sample to investigate
the following: (1) the prevalence of EDS in TTH individuals; (2)
the clinical presentations of TTH associated with EDS; (3) The
factors contributing EDS occurrence in TTH individuals.
MATERIALS AND METHODS
Study Protocol
We conducted a cross-sectional study to analyze data from
the Korean Headache-Sleep Study (KHSS), which is a national
population study for headache and sleep. Detailed methods
of this survey were previously described (12). Briefly, two-
stage random cluster sampling was used to reflect the
regional distribution in Korea except for Jeju-do. Well-
trained interviewers performed this survey by door-to-door
visiting using a structured questionnaire. The questionnaire was
composed of questions asking yes-no answers or Likert scales.
Each participant provided informed consent before the survey
and the study protocol was reviewed and approved by the
Institutional Review Board and Ethics Committee of Hallym
University Sacred Heart Hospital (Approval No. 2011-I077).
Headache Assessment
Participants that experienced more than 1min of headache
during the previous year, they were classified as having headache.
If participants did not experience a headache lasting more
than 1min during the previous year, they were classified as
participants without headache.
TTH Assessment
For TTH diagnosis, we used diagnostic criteria B to D for
infrequent episodic TTH (code 2.1) in the third edition, beta
version of the International Classification of Headache Disorders
(ICHD-3 beta) (B: lasting from 30min to 7 days; C: at least two of
the following four characteristics [i.e., bilateral location, pressing
or tightening (non-pulsating) quality, mild ormoderate intensity,
and not aggravated by routine physical activity such as walking or
climbing stairs]; D: attacks associated with both of the following:
no nausea or vomiting and no more than one of photophobia
or phonophobia). Participants who fulfilled these criteria were
classified as having TTH. Diagnostic criterion A (at least 10
episodes of headache) was not applied in TTH diagnosis. Thus,
TTH individuals included in this study had infrequent TTH
(code 2.1), frequent TTH (code 2.2), and chronic TTH (code 2.3).
If a participant classified as having headache and fulfilling B to
D criteria for infrequent episodic TTH, she/he was classified as
having TTH. Based on ICHD-3 beta, participants that fulfilled
with both diagnostic criteria for probable migraine (PM) and
TTH were considered as having TTH.
EDS Assessment
The Epworth Sleepiness Scale (ESS) was used for EDS assessment.
The total ESS score ranges from 0 to 24 points. Participants with
a score equal to or >11 were considered as having EDS. We used
a previously verified Korean version of ESS (13).
Short Sleep Duration and Poor Sleep
Quality Assessment
Short sleep duration was defined as an average sleep duration of
6 h or less. The average sleep duration was calculated using the
following formula; [(workday sleep duration × 5) + (free day
sleep duration × 2)]/7; the sleep durations on the weekdays and
free days were independently measured using the survey data on
sleep onset and wakeup time.
The Pittsburgh Sleep Quality Index (PSQI) was adopted to
assess sleep quality. The PSQI consists of 19 questions on various
aspects of perceived sleep status. The total PSQI score ranges
from 0 to 21 points. Poor sleep quality was defined as a PSQI score
of 6 or more (14).
Anxiety and Depression Assessment
Anxiety was assessed using the Goldberg Anxiety Scale (GAS),
which is composed of a total of nine items, four screening
items, and five supplementary items (15). Participants who had
five or more positive answers for all the items, with two or
more being for the screening items, were considered as having
anxiety. The Korean version GAS has a sensitivity of 82.0% and
a specificity of 94.4% for diagnosing anxiety (16). This study
evaluated depression using the Patient Health Questionnaire-9
(PHQ-9) (17). The PHQ-9 was developed based on the DSM-
IV criteria for major depression and has been widely used in
epidemiological studies (18–20). Response options were rated
on a four -point scale from 0 to 3, regarding the past 2 weeks
experienced. Participants with a PHQ-9 score of 10 or more were
classified as having depression. The sensitivity and specificity of
the Korean version of PHQ-9 were previously validated as 81.1
and 89.9%, respectively (21).
Statistical Analysis
Normality of distribution was evaluated using Kolmogorov–
Smirnov test. After normality of distribution was confirmed,
Student’s t-test was used to compare two groups. If the normality
of distribution was not confirmed, Mann–Whitney U-test was
used to compare two groups. Chi-square test was used to
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compare the prevalence rates. Univariable and multivariable
analyses were performed to determine factors contributing to
EDS among TTH individuals. For univariable analyses, factors
with significant differences between TTH individuals with EDS
and those without EDS were considered. For multivariable
analyses, three models were developed to examine the association
between EDS and TTH. In Model 1, sociodemographic factors
(sex, age, size of residential area, and level of education) were
adjusted. In Model 2, sociodemographic factors and sleep-
related parameters (short sleep duration and poor sleep quality)
were adjusted. In Model 3, sociodemographic factors and
psychiatric comorbidity (anxiety and depression) were adjusted.
In the final model (Model 4), sociodemographic factors, sleep-
related parameters, and psychiatric comorbidity were adjusted.
Statistical Package for Social Sciences version 22.0 (SPSS 22.0;
IBM, Armonk, NY, USA) was used for all statistical analysis.
Statistical significance was defined as a two-tailed p < 0.05.
Several variables had missing data because of non-response.
Available data were used for the final analysis. There was no
missing data for all 2,695 participants except for educational level,
which had 26 non-respondents.
RESULTS
Survey
We approached 7,430 subjects and 3,114 (41.9%) subjects agreed
to respond to the survey. Finally, 2,695 (36.3%) participants
completed the survey (Figure 1). Collected data on demographic
factors (age, sex, size of residential area, and level of education)
revealed no significant difference from that of the Korean general
population (Table 1).
Prevalence of TTH, Non-headache, and
EDS
Of the 2,695 participants, 570 (21.2%) had TTH while 1,422
(52.8%) did not have a headache during the previous year.
Among TTH individuals, 113 (19.8%) also had PM. Three-
hundred and thirteen (11.6%) participants were classified as
having EDS (Table 1).
Prevalence of Anxiety, Depression, Short
Sleep Duration, and Poor Sleep Quality
A total of 268 (9.9%) participants had anxiety while 116 (4.3%)
had depression. The prevalence rates of anxiety (9.5 vs. 5.3%, p=
0.001) and depression (4.2 vs. 1.8%, p= 0.001) were significantly
higher among TTH individuals than among individuals without
headache. A total of 469 (17.4%) participants reported having an
average sleep duration of<6 h, and were classified as having short
sleep duration. A total of 715 (26.5%) participants were classified
as having poor sleep quality.
EDS Prevalence in Individuals With TTH
Among the 570 participants with TTH, 63 (11.1%) reported
experiencing EDS. The EDS prevalence in individuals with TTH
FIGURE 1 | Flow chart depicting the participation of subjects in the Korean Headache-Sleep Study.
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TABLE 1 | Demographic characteristics of the survey participants; total population; and participants with tension-type headache (TTH) and excessive daytime sleepiness
(EDS).
Survey participants, N (%) Total population, N (%) P TTH, N, % (95% CI) EDS, N, % (95% CI)
Sex
Men 1,345 (49.3) 17,584,365 (50.6) 0.854* 268, 19.9 (17.8–22.0) 161, 12.0 (10.2–13.7)
Women 1,350 (50.7) 17,198,350 (49.4) 302, 22.3 (20.1–24.6) 152, 11.3 (9.6–12.9)
Age
19–29 542 (20.5) 7,717,947 (22.2) 0.917* 119, 22.0 (18.5–25.5) 52, 9.6 (7.1–12.1)
30–39 604 (21.9) 8,349,487 (24.0) 127, 21.0(17.8–24.3) 71, 11.8 (9.2–14.3)
40–49 611 (23.1) 8,613,110 (24.8) 131, 21.4 (18.2–24.7) 62, 10.1 (7.7–12.5)
50–59 529 (18.9) 6,167,505 (17.7) 107, 20.2 (16.8–23.7) 66, 12.5 (9.7–15.3)
60–69 409 (15.6) 3,934,666 (11.3) 86, 21.0 (17.1–25.0) 62, 15.2 (11.7–18.6)
Size of residential area
Large city 1,248 (46.3) 16,776,771 (48.2) 0.921* 251, 20.1 (17.9–22.4) 150, 12.0 (10.2–13.8)
Medium-to-small city 1,186 (44.0) 15,164,345 (43.6) 243, 20.5 (18.2–22.8) 134, 11.3 (9.5–13.1)
Rural area 261 (9.7) 2,841,599 (8.2) 76, 29.1 (23.6–34.7) 29, 11.1 (7.3–14.9)
Education level
Middle school or less 393 (14.9) 6,608,716 (19.0) 0.752* 96, 24.5 (20.1–28.7) 58, 14.8 (11.2–18.3)
High school 1,208 (44.6) 15,234,829 (43.8) 247, 20.5 (18.2–22.7) 135, 11.2 (9.4–13.0)
College or more 1,068 (39.6) 12,939,170 (37.2) 223, 20.9 (18.4–23.3) 119, 11.1 (9.3–13.0)
Not responded 4, 15.4 (0.5–30.2) 1, 3.8 (0.0–11.8)
Total 2,695 (100.0) 34,782,715 (100.0) 570, 21.2 (19.6–22.7) 313, 11.6 (10.4–12.8)
*Comparison of sex, age group, size of residential area, and educational level distributions between the sample in the present study and the total population of Korea.
TTH, tension-type headache; EDS, excessive daytime sleepiness; N, number; CI, confidence interval.
was not significantly different from that in individuals without
headache (11.1 vs. 9.4%, p = 0.271). The prevalence of EDS was
not significantly different between TTH participants fulfilling PM
criteria and TTH participants not-fulfilling PM (11.6 vs. 8.8%,
p= 0.404).
EDS prevalence was analyzed with regard to headache
frequency. Individuals with 15 or more TTH attacks per month
had a significantly higher EDS prevalence compared to that those
without headache (35.7 vs. 9.4%, p < 0.001). Individuals with 1–
14 TTH attacks per month (13.5 vs. 9.4%, p = 0.054) and with
<1 attack per month (8.3 vs. 9.4%, p = 0.511) did not have a
significantly different EDS prevalence compared to those without
headache (Figure 2).
Clinical Presentation of TTH According to
the Presence of EDS
Osmophobia and depression were more prevalent among
TTH participants with EDS compared to those without. TTH
participants with EDS showed significantly higher headache
frequency, visual analog scale (VAS) scores for headache
intensity, and Headache Impact Test-6 scores compared to those
without EDS (Table 2).
Univariable and Multivariable Analysis for
Contributing Factors to EDS Among TTH
Individuals
Univariable analysis showed that depression (odds ratio [OR] =
4.5, 95% confidence interval [CI] = 1.8–10.9) and poor sleep
FIGURE 2 | Prevalence of excessive daytime sleepiness according to the
frequency of tension-type headache. *p < 0.05.
quality (OR = 5.0, 95% CI = 2.9–8.7) were associated with an
increased risk of EDS in TTH individuals. Multivariable analysis
of sociodemographic factors revealed no statistically significant
association with EDS (Model 1). In Model 2, which included
sociodemographic factors, depression, and anxiety, depression
(OR= 4.5, 95%CI= 1.7–11.7) showed increasedORs for EDS. In
Model 3, which included sociodemographic factors, short sleep
time, and poor sleep quality, poor sleep quality (OR= 6.6, 95%CI
= 3.6–12.1) showed increased ORs for EDS; however, high school
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TABLE 2 | Demographics and clinical presentation of individuals with tension-type
headache (TTH) according to the presence of excessive daytime sleepiness (EDS).
TTH with EDS
(N = 63)
TTH without EDS
(N = 507)
P
Demographics
Mean age ± SD (years) 45.4 ± 13.5 42.4 ± 13.7 0.092
Women, N (%) 31 (49.2) 271 (53.5) 0.524
Headache characteristics
Bilateral pain, N (%) 36 (57.1) 338 (66.7) 0.133
Non-pulsating quality,
N (%)
24 (38.1) 203 (40.0) 0.766
Mild-to-moderate severity,
N (%)
62 (98.4) 498 (98.2) 0.915
Non-aggravation by
movement, N (%)
51 (81.0) 400 (78.9) 0.705
Associated symptoms
Photophobia, N (%) 6 (9.5) 40 (7.9) 0.653
Phonophobia, N (%) 22 (34.9) 159 (31.4) 0.567
Osmophobia, N (%) 17 (27.0) 78 (15.4) 0.020
Headache frequency per
month, mean ± SD
4.3 ± 8.1 1.7 ± 4.2 0.013
VAS score, mean ± SD 4.9 ± 1.6 4.3 ± 1.9 0.007
HIT-6 score, mean ± SD 47.1 ± 7.3 43.5 ± 7.6 <0.001
Anxiety 9 (14.3) 45 (8.9) 0.167
Depression 8 (12.7) 16 (3.2) <0.001
TTH, tension-type headache; EDS, excessive daytime sleepiness; N, number; SD,
standard deviation; VAS, visual analog scale; HIT-6, headache impact test-6.
graduates (OR = 0.4, 95% CI = 0.1–0.9) showed decreased ORs
for EDS. In Model 4, which included sociodemographic factors,
anxiety, depression, short sleep time, and poor sleep quality, poor
sleep quality (OR = 6.0, 95% CI = 3.2–11.2) showed increased
ORs for EDS while high school graduates (OR = 0.4, 95% CI =
0.1–0.9) showed decreased ORs for EDS (Table 3).
DISCUSSION
The key findings of this study include: (1) The overall prevalence
of EDS in TTH participants was similar to that in participants
without headache; (2) The prevalence of EDS among individuals
with chronic tension-type headache (CTTH) was higher than
that in individuals with episodic tension-type headache (ETTH)
and without headache; and (3) TTH participants with EDS had a
higher headache frequency, severe headache intensity, increased
impact of headache, and a higher prevalence of depression
compared to TTH participants without EDS.
There have been limited reports on the prevalence and impact
of EDS in TTH. The prevalence of EDS in CTTH participants
was found to be similar to that in participants with chronic
migraine (CM). It has also been reported that individuals with
a headache frequency ≥80 per 3 months experience EDS more
frequently compared to those with a headache frequency <80
per 3 months (22). Moreover, a previous study reported that
EDS prevalence in TTH individuals did not significantly differ
from that in individuals without headache (9). However, the
prevalence of EDS among individuals with CTTH in comparison
with those with ETTH and without headache has not yet been
reported in a population-based setting. The present study is the
first to report a significantly higher prevalence of EDS among
individuals with CTTH compared to that in individuals with
ETTH and individuals without headache.
Epidemiological studies have reported the prevalence of
EDS to range from 8 to 30%. A Singaporean study reported
an EDS prevalence of 9.0% (23). A Korean population-based
study using data from the Korean Genome Epidemiology Study
found an EDS prevalence of 12.2% (24). An Australian study
reported an EDS prevalence of 15.3% (25). The similarity in EDS
prevalence between this study and previous studies suggests that
the assessment of EDS in this study is reliable.
The present study found that the overall prevalence of EDS
in TTH individuals was similar to that in individuals without
headache; however, the EDS prevalence in CTTH individuals
was higher than in ETTH and individuals without headache.
These findings are similar to those of a Norwegian study that
reported that the overall EDS prevalence in TTH individuals
was similar to that in non-headache individuals (9). In this
previous study, the prevalence of EDS in CTTH, which was
reported to be higher in individuals without headache (8, 9), was
similar to that in individuals with CM. The prevalence of EDS
in CTTH individuals (35.7%) in the present study was somewhat
higher than that in the Norwegian study (20.8%). One possible
explanation for this discrepancy is the difference in ethnicity
and sociodemographic distribution between the two studies.
A possible reason for sociodemographic distribution difference
could be that while our study used data from the KHSS, which
sampled participants proportionally to the regional distribution
in Korea, the Norwegian study used a community-based sample
aged 30–44 from Akershus County, Norway. Therefore, this
difference in sociodemographic distribution may account for
the discrepancy in the prevalence of EDS in CTTH individuals
between the two studies.Moreover, the cultural difference in ways
of reporting sleepiness could be another source of discrepancy.
A previous study reported large variations in the EDS prevalence
across the world (26), with the difference in surveymethods being
another possible explanation for the discrepancy.
EDS is defined as the inability to stay awake and alert during
major working episodes of the day, resulting in periods of
irrepressible need for sleep or unintended lapses into drowsiness
or sleep, based on the third edition of International Classification
of Sleep Disorders (27). EDS is one of the most disabling
conditions caused by poor nocturnal sleep and can lead to poorer
occupational and social functioning, and is strongly related to
an increased risk of vehicular and occupational accidents (28,
29). The present study found that a significant proportion of
individuals with TTH had EDS. Considering the effect of EDS
and daytime dysfunction, some of burden by TTH could be
attributed to EDS. Therefore, proper diagnosis and treatment of
EDS in TTH could be a useful way to reduce burden of TTH.
Univariable analysis in the present study showed that
depression and poor sleep quality among TTH individuals
were significant factors for EDS. After adjusting for potential
covariates, multivariable analyses only showed high school
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TABLE 3 | Logistic regression for the contributing factors of excessive daytime sleepiness (EDS) among individuals with tension-type headache (TTH).
Univariable
analysis OR,
95% CI
Multivariable
analysis OR, 95%
CI (Model 1)
Multivariable
analysis OR, 95%
CI (Model 2)
Multivariable
analysis OR, 95%
CI (Model 3)
Multivariable
analysis OR, 95%
CI (Model 4)
Sex 1.2 (0.7–2.0) 1.2 (0.7–2.1) 1.2 (0.7–2.1) 1.2 (0.7–2.2) 1.2 (0.7–2.2)
Age
19–29 Reference Reference Reference Reference Reference
30–39 1.5 (0.6–3.6) 1.6 (0.7–4.0) 1.5 (0.6–3.8) 1.4 (0.6–3.6) 1.4 (0.6–3.5)
40–49 1.7 (0.7–4.0) 1.9 (0.8–4.6) 1.9 (0.8–4.6) 2.0 (0.8–5.0) 2.0 (0.8–5.0)
50–59 1.4 (0.6–3.5) 1.2 (0.4–3.5) 1.3 (0.4–3.6) 1.0 (0.3–2.9) 1.0 (0.3–3.1)
60–69 2.2 (0.9–5.4) 1.7 (0.6–5.3) 1.8 (0.6–5.4) 1.5 (0.5–4.6) 1.5 (0.5–4.7)
Size of residential area
Large city Reference Reference Reference Reference Reference
Medium-to-small city 1.2 (0.7–2.0) 1.2 (0.7–2.0) 0.5 (0.2–1.2) 1.2 (0.7–2.1) 1.1 (0.6–2.0)
Rural area 0.4 (0.2–1.3) 0.4 (0.7–2.1) 0.6 (0.2–1.6) 0.4 (0.1–1.2) 0.4 (0.1–1.2)
Educational level
Middle school or less Reference Reference Reference Reference Reference
High school 0.6 (0.3–1.2) 0.5 (0.2–1.2) 0.5 (0.2–1.2) 0.4 (0.1–0.9) 0.4 (0.1–0.9)
College or more 0.7 (0.3–1.3) 0.6 (0.2–1.6) 0.6 (0.2–1.6) 0.4 (0.2–1.2) 0.4 (0.2–1.3)
Anxiety 1.7 (0.8–3.7) 1.2 (0.5–2.8) 1.1 (0.5–2.7)
Depression 4.5 (1.8–10.9) 4.5 (1.7–11.7) 1.8 (0.7–5.3)
Short sleep duration (<6 h) 1.2 (0.6–2.2) 0.5 (0.3–1.1) 0.5 (0.3–1.1)
Poor sleep quality (PSQI >5) 5.0 (2.9–8.7) 6.6 (3.6–12.1) 6.0 (3.2–11.2)
Model 1, adjusted for sociodemographic factors (age, sex, size of residential area, educational level); Model 2, adjusted for sociodemographic factors, anxiety, and depression; Model
3: adjusted for sociodemographic factors, short sleep duration, and poor sleep quality; Model 4, adjusted for sociodemographic factors, anxiety, depression, short sleep duration, and
poor sleep quality. OR, odds ratio; CI, confidence interval; PSQI, pittsburgh sleep quality index.
educational level and poor sleep quality as significant factors
for EDS. These findings are similar to those of other studies on
the association between EDS and migraine. A Norwegian study
revealed that a high headache frequency and depression were
significant factors for EDS in migraineurs and TTH individuals
(9). Our previous study also found that depression and poor sleep
quality were significant factors for EDS in migraineurs (8). These
findings suggest that EDS in CM and CTTH may be improved
by improving depression and poor sleep quality. Depression has
been shown to be successfully treated by pharmacological and
non-pharmacological treatment (30). A previous study reported
that poor sleep quality was closely associated with insomnia
and that insomnia could be successfully managed by improving
sleep hygiene, behavioral cognitive therapy, pharmacological
treatment, etc. (31). Considering that EDS is associated with an
exacerbation of TTH symptoms, improving EDS may be helpful
in improving TTH symptoms.
This study has several limitations. First, this study assessed
EDS using the ESS rather than objective measurement. ESS
is a simple self-administered questionnaire, and is the most
widely used tool for assessing subjective sleepiness. The ESS
score is highly correlated with partners’ independent reports
of the subjects’ report (32). There is evidence on the validity
of ESS and its usefulness in assessing EDS and its changes
after treatment (33–35). We used the Korean version of the
ESS, which was validated in Korean patients. This ensured
that we had successfully evaluated EDS in the participants
from the Korean general population. Nevertheless, objective
measurement may provide more information regarding total
sleep time, sleep architecture, sleep efficacy, and other sleep
derivatives. Second, we did not investigate medication use in the
present study. Various medications, including anticonvulsants,
antidepressants, antiemetics, antihistamines, antihypertensives,
hypnotics, and muscle relaxants, may affect sleepiness (3). Third,
the response rate in this study, which was 36.3%, was not
high. However, we used two-stage random clustered sampling
to reflect the population distribution in Korea. Moreover, there
was no significant difference in the sociodemographic factors
between participants in the present study and the Korean
general population. Further, the prevalence of TTH and EDS
was similar to that reported in previous studies. Lastly, we
used 1-year time interval for the assessment of headache,
TTH and without headache. Consequently, participants with
TTH experienced TTH attack less than one attack per
year, they were classified as participants without headache.
We did not investigate participants’ life-time headache or
TTH and could not assess the difference in EDS prevalence
between participants without TTH during their lifetimes
and TTH participants experiencing less than one attack
per year.
This study has several strengths. First, this study adopted the
Korean version of the used questionnaires, which were previously
validated for evaluating TTH, EDS, anxiety, depression, and
poor sleep quality. Second, this study used a sample that
reflected the Korean general population distribution, which
allowed us to accurately investigate the prevalence of TTH, EDS,
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anxiety, depression, and poor sleep quality with a low sampling
error. Third, we investigated potential covariates, including
sociodemographic factors, anxiety, depression, and poor sleep
quality for EDS, and analyzed the contributing factors to EDS
in TTH.
CONCLUSION
Although the overall prevalence of EDS in TTH individuals
was not significantly different from that in individuals without
headache, CTTH individuals had a higher prevalence of
EDS compared to ETTH and individuals without headache.
Furthermore, TTH participants with EDS experienced more
severe symptoms of TTH compared to those without EDS.
Therefore, EDS should be carefully investigated during the
management of TTH.
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